PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)
- Citation:
- NPJ Breast Cancer vol 2 15023
- Year:
- 2016
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- 849 is parent abstract
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- Yes
- Book Volume:
- 5
- Parents:
- 849
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171, N01 CA032102, U10 CA021115, U10 CA031946, U10 CA033601, U10 CA180821, U01 CA114722, U10 CA032102, U10 CA180882, U24 CA196171, U24 CA114736, U10 CA025224
- Corr. Author:
- Authors:
- Minetta C Liu Brandelyn N Pitcher Elaine R Mardis Sherri R Davies Paula N Friedman Jacqueline E Snider Tammi L Vickery Jerry P Reed Katherine DeSchryver Baljit Singh William J Gradishar Edith A Perez Silvana Martino Marc L Citron Larry Norton Eric P Winer Clifford A Hudis Lisa A Carey Philip S Bernard Torsten O Nielsen Charles M Perou Matthew J Ellis William T Barry
- Networks:
- LAPS-CT018, LAPS-IL036, LAPS-MN026, LAPS-NC007, LAPS-NC010, LAPS-NY016, NORTHWELL, OZARKS, PR028, TX041
- Study
- CALGB-159905
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-9741
- Phases:
- N/A, 3
- Keywords:
- Article